Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Time to load up with these shares, stock is rock solid at these levels.
$mmirf $0.23469 ^ 0.00969 (4.31%)
Volume: 73,425 @02/19/21 3:48:17 PM EST
The dip is in from .52 good entry point at .35
BREAKOUT .43 cents up 68%
News pending
Stock trades quite heavy under their Canadian ticker symbol MIR.V
$mmirf $0.17897 ^ 0.00251 (1.42%)
Volume: 1,500 @01/06/21 9:30:22 AM EST
11,442,248 shares traded in Canada under the ticker symbol MIR.v Dec31, 2020 and 169,000 shares traded in America under the ticker symbol MMIRF.
Going to be a whole bunch of news and developments this first quarter of 2021..........stay tuned
Medmira going to all time highs this year........2021 is the year of the breakout for MMIRF / MIR.v
NEWS RELEASE: Product update, looks like a new bull run will start today with no end in sight
https://www.globenewswire.com/news-release/2020/12/31/2151927/0/en/MedMira-Announces-Product-Update.html
$mmirf $0.1843 v -0.0057 (-3.00%)
Volume: 118,175 @12/16/20 2:54:18 PM EST
$mmirf $0.1959 v -0.002864 (-1.44%)
Volume: 9,020 @12/11/20 1:01:40 PM EST
Bid Ask Day's Range
0.198764 0.198764 0.194588 - 0.1959
revenue way up, stock going to run
$mmirf $0.2204 ^ 0.01647 (8.08%)
Volume: 41,255 @11/25/20 3:59:17 PM EST
$mmirf $0.19139 ^ 0.01491 (8.45%)
Volume: 63,100 @11/19/20 3:02:33 PM EST
Bid Ask Day's Range
- - 0.172831 - 0.19802
$mmirf $0.177 v -0.021 (-10.61%)
Volume: 46,811 @11/09/20 3:25:15 PM EST
$mmirf $.50 with news
$mmirf $0.212863 v -0.003137 (-1.45%)
Volume: 17,450 @10/30/20 10:18:53 AM EDT
$mmirf $0.22093 v -0.00907 (-3.94%)
Volume: 400 @10/22/20 12:05:10 PM EDT
Need that FDA stamp of approval... so quite
Quick Covid-19 Test are back in the forefront of news!!! IMHO FDA Approval Right Around the Corner!
$mmirf $0.2076 v -0.000462 (-0.22%)
Volume: 12,415 @10/02/20 2:16:31 PM EDT
$mmirf $0.2164 v -0.00391 (-1.77%)
Volume: 14,617 @09/29/20 2:45:15 PM EDT
Copied from another board
We had such an incredible afternoon today at MedMira Inc. Laboratory in #ClaytonParkWest!
#MedMira has come out with a patent for #COVID19 that can detect if you have antibodies within minutes, and will show the results for days to follow (which is something that is not common with these types of tests).
Just a few short months ago, 6 months to be exact, MedMira only had 11 staff members. Today, the company has expanded to 54 people! It was truly amazing to see all of their employees who come from over 18 countries; there are 6 summer students and over 30 new immigrants.
The expansion of staff is due to the high demand for their REVEALCOVID-19 TM Total Antibody test.
One of the most valuable things we noticed is that these individuals are extremely hard-working. This job is an exceptional way for them to get the Canadian working experience and to have flourishing and enriching careers!
We felt a true sense of family and community — this is the real beauty of Canada; There is opportunity and space for everyone to work in harmony.
The staff at MedMira contribute a weekly production of over 20,000 COVID-19 tests. We are told that the external performance evaluation of this product in the United States has been exceptional.
They also plan to expand to other markets, such as Europe and Asia.
Please stay tuned for a special feature from my office, highlighting a behind-the-scenes look at MedMira Inc.
Thank you to Hermes Chan (CEO) and Markus Meile (CFO), for your information breakdown of the antibody test. As well as all the exciting things your company is doing and plans to do in the future.
We wish you the best of luck!
Should be a green day today
Just a few short months ago, 6 months to be exact, MedMira only had 11 staff members. Today, the company has expanded to 54 people! It was truly amazing to see all of their employees who come from over 18 countries; there are 6 summer students and over 30 new immigrants.
GREAT WRITE UP FROM CANADIAN POLITICIAN
https://www.facebook.com/134268600446739/posts/808411506365775/?extid=gZpJa2yakqi1gWjA&d=n
Need the FDA approval... anytime now
FDA Approval ANYDAY!!! Best Test on the Market!! !
New German report puts a target price of $1.50 to $1.75 on MedMira short term and $3 a share long-term. Thanks in part to their latest news release on September 3.
https://www.wallstreet-online.de/nachricht/12902844-medmira-vorwaerts-lang-wars-ruhig-medmira-artikel-globe-newswire-facht-spekulation-an
Yep very nice day for Medmira
FDA will approve before months end. From today's news release it can be seen our tests meet the FDA criteria. Good luck tomorrow
WHO IS THE DICK !! THAT PUT THAT CRAP UP TOP OF PAGE AZZ!!!
ALIFAX, Nova Scotia, Sept. 03, 2020 (GLOBE NEWSWIRE) -- Today, MedMira Inc. (MedMira) (TSXV: MIR) reports findings to further emphasize the high sensitivity of REVEALCOVID-19™ Total Antibody Test 7 days post symptom onset as well as highlights the test’s zero cross-reactivity (i.e. no false positive results) with HIV positive samples.
https://ca.finance.yahoo.com/news/revealcovid-19-total-antibody-test-210000021.html
NEWS RELEASE SEPTEMBER 3, 2020 after market close:
https://ca.finance.yahoo.com/news/revealcovid-19-total-antibody-test-210000021.html
But they can sell during the review period.......I think tomorrow is going to be a good day for the stock, with the run to .38 a few days ago and today's close at the high
I agree... just seems like the FDA is delaying potential the best test available (medmira) while approving Abbott test that are less accurate.
Think it is overdue, but I read that they are extra vigilant due to their past acceptance of less than adequate tests in the initial panic. Hermes Chan just posted on linked in (from stockhouse post):
The study reveals key finding about specific IgM, IgG1, and IgA1 antibody not only present in plasma or serum of almost all analyzed COVID-19 convalescent study subjects, most significantly is that these antibodies were also detected at exceptionally early stages of the infection (i.e., 7-8 days after disease onset).
This may set a new criteria and create great opportunity for serological tests used in screening convalescent plasma for the emergency therapeutic application critical for treating severe COVID-19 patients.
Any clue about the delay of fda approval?
Followers
|
2
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
105
|
Created
|
02/10/17
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |